Target intelligence / Profile preview

Long intergenic non-protein coding RNA 917 (LINC00917)

Target
LINC00917
Molecular classification
Long non-coding RNA (lncRNA), Other (specifically, long intergenic non-protein coding RNA)
01

Overview

LINC00917 (long intergenic non-protein coding RNA 917) is a long non-coding RNA gene located on chromosome 16q24, defined by its lack of protein-coding potential and its position between protein-coding genes[1][5]. LINC00917 participates in gene regulatory networks, exerting its functions by acting as a competing endogenous RNA (miRNA sponge), particularly for miR-149-5p, which impacts the regulation of targets such as NLRP1 involved in inflammation and pyroptosis[2][3]. Its dysregulation has been linked to intervertebral disc degeneration, where it is upregulated and promotes pathological processes such as reduced cell proliferation and increased inflammatory cell death in nucleus pulposus cells[2][3]. Additionally, elevated levels of exosomal LINC00917 in serum have been associated with non-small cell lung cancer, correlating with advanced disease stage and worse prognosis, suggesting a potential role as a non-invasive biomarker[4][6]. No current evidence supports its direct targeting by therapeutic drugs.

Other names
LINC00917Long intergenic non-protein coding RNA 917
02

Mechanism of action

Not applicable. As an lncRNA, LINC00917 does not have mechanisms of action analogous to proteins; its influence is mediated through *RNA-RNA interactions* and regulation of microRNAs (notably acting as a sponge for miR-149-5p, thereby modulating the expression of targets such as NLRP1)

03

Biological functions

Regulation of gene expression by acting as a competing endogenous RNA ("miRNA sponge")Modulation of cell proliferation (notably in nucleus pulposus cells, relevant to intervertebral disc degeneration)Regulation of pyroptosis (inflammation-associated programmed cell death)Possible involvement in RNA-level regulation associated with tumorigenesis
04

Disease associations

Cancer (biomarker potential for non-small cell lung cancer; association with cancer stage and survival)Intervertebral disc degeneration (IDD)Inflammation-related disease processes
05

Biomarkers

Exosomal LINC00917 (as a serum-derived RNA biomarker for non-small cell lung cancer diagnosis and prognosis)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 917 (LINC00917).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 917 (LINC00917).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call